Indivenire
- Company typePrivate
- Founded2018
- HeadquartersTrento, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
Indivenire firmographics
Firmographics- Name
- Indivenire
- Legal name
- Indivenire srl
- Website
- https://indiveni.re
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Indivenire industry classification
Industry- Product category
- Biotechnology Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Instrumentation, Controls & Automation Engineering Consulting (BPAHAIAM)
Keywords
Where Indivenire is headquartered
LocationHeadquarters
- HQ city
- Trento
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
Indivenire business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- R&D Outsourcing Services: Fee-for-service research and development contracts with SMEs. Clients pay for outsourced R&D services including problem-solving, product development, and scientific consultancy. Revenue is project-based, with contracts covering various research activities from concept to execution.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Indivenire product offering
Product offeringCore offering
Indivenire provides outsourced research and development services to small and medium enterprises that cannot afford internal R&D departments. The company delivers project-based R&D contracting across biosensors, biomedical devices, molecular diagnostics, surface analysis, and biomaterials, leveraging access to specialized laboratory infrastructure at FBK (LABSSAH and MNF facilities) and a network of academic and research collaborators to help SMEs develop new products and solve technical problems without maintaining in-house staff, equipment, or laboratory space.
Product overview
Indivenire is an R&D outsourcing company that provides small and medium enterprises with access to external research and development capabilities. Their core offering is R&D outsourcing services supported by specialized laboratory facilities including the LABSSAH laboratory at FBK with four platforms (Bio-imaging, Bio-functional materials, Nanopores analysis, and NGS), and the MNF Micro Nano characterization facility. They offer surface analysis services using techniques including XPS (X-Ray Photoelectron Spectroscopy), ToF-SIMS, and SIMS. Their service portfolio includes Point of Care (POC) device development assistance, biomaterial study and improvement, interface characterization and modification, and funding assistance for R&D projects. The company operates in biosensors, health, quality of life, lab-on-a-chip, thin films, food processing, and surface treatment domains.
Differentiator
Problem solved
Functional benefit
Products and services
- R&D Outsourcing Services Outsourced research and development services providing small and medium enterprises with access to highly qualified scientific staff and laboratory facilities for sample preparation, micro-analysis, and micro-processing, enabling them to develop new products and solve technical problems without maintaining internal R&D departments.
- LABSSAH Laboratory Services Laboratory services housed at FBK featuring four specialized platforms: Bio-imaging, Bio-functional materials, Analysis techniques using nanopores, and Technologies for massive and parallel sequencing of nucleic acids (NGS). Equipment includes cell/molecular biology tools, microscopy, spectroscopy, and AFM.
- MNF Micro Nano Characterization and Fabrication Micro Nano characterization and fabrication facility services in collaboration with FBK providing access to advanced materials and microsystems characterization for microdevice development.
- X-Ray Photoelectron Spectroscopy (XPS) Surface analysis technique used to analyze elements constituting sample surfaces, providing information about elements present within a few nanometers from the surface and their chemical bonding state.
- Time Of Flight Secondary Ion Mass Spectrometry (ToF-SIMS) Surface analysis technique based on a sputtering process that analyzes the first layer of samples with very high detection sensitivity for elements or molecular species.
- Secondary Ion Mass Spectrometry (SIMS) Surface analysis technique using ion bombardment to cause erosion of sample surface and emission of secondary ions for dopant and impurity analysis with depth profiling capabilities.
- Point of Care (POC) Development Assistance Expertise in developing point-of-care devices including the crucial interface design using antibodies or aptamers immobilized on surfaces for analyte recognition in biological samples.
- Biomaterial Study and Improvement Services to study and improve biomaterials including nano/micro structured surfaces, porous surfaces, and surface treatments for better integration.
- Interface Characterization and Modification Analysis and modification of material interfaces (the few nanometers on a material's surface in contact with the environment) for applications in medical devices, food storage, gas sensors, and coatings.
- Funding Assistance Services Support in seeking funding for clients, including assistance with Italian tax credits for research and development, innovation, and design under Legge di bilancio 2021, with up to 150% credit on qualifying R&D expenditures.
Companies that use Indivenire
Customer profileSegments1 record
Ideal customer profiles1 record
Indivenire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Indivenire partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- FUTURBIO (European Erasmus+ Project)minorIndivenire is a partner in FUTURBIO, a European Erasmus+ project focused on teaching and training related to biodegradable plastics. The project started in February 2022 and runs until February 2024. This partnership contributes to educational and training initiatives in sustainable materials.
- LIDIA Project (Litografia ad alta risoluzione per sensori biomedicali)minorIndivenire participates in the LIDIA project exploring new lithographic technology for biomedical sensors. Laura Pasquardini from Indivenire is part of the project team led by Georg Pucker at FBK, along with partners FTH srl and Microfabsolutions srl.
- SiPoBio Project (Portable system for high sensitivity detection of circulating biomarkers in blood)minorIndivenire participates in the SiPoBio project developing a portable system for high sensitivity detection of circulating biomarkers in blood. The project, led by Cristina Potrich at FBK, aims to improve prevention, diagnosis, and treatment through functional surfaces and optimized reading systems.
- FBK (Fondazione Bruno Kessler)coreFBK hosts Indivenire's laboratory (LABSSAH) and provides access to advanced infrastructure including MNF (Micro Nano characterization and fabrication facility). This is a core partnership providing essential laboratory space and equipment access.
- HIT (Hub Innovazione Trentino)minorIndivenire is supported by HIT (Hub Innovazione Trentino) which provides institutional backing and innovation ecosystem connections in the Trentino region.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Indivenire competitors and assessment
Company assessmentBroad incumbents
- WuXi AppTec: Global contract research, development, and manufacturing organization offering outsourced services from discovery through commercial manufacturing. Comparable to Indivenire in the CRO/R&D outsourcing business model; vastly larger scale, but shares the same value proposition of monetizing scientific infrastructure and expertise on behalf of resource-constrained clients.
- Intertek Group: Global testing, inspection, and certification firm with a life sciences and laboratory services division. Comparable to Indivenire in providing outsourced laboratory and analytical services using advanced instrumentation; much broader industry coverage and geographic footprint, but same fundamental model of monetizing instrument access and scientific expertise for clients.
- ICON plc: Global clinical research organization providing outsourced development and laboratory services. Comparable as a contract research services firm; though ICON is focused on clinical trials and larger biopharma, the underlying model of monetizing scientific infrastructure and talent via project-based contracts mirrors Indivenire's approach.
- GenScript Biotech: Global biotechnology services company offering gene synthesis, peptide/protein services, and contract research for life science clients. Comparable to Indivenire as a fee-for-service scientific services provider serving clients that lack internal lab capabilities; broader service menu and global scale, but same underlying model of monetizing scientific infrastructure.
- Catalent: Global CDMO providing development and delivery services for drugs, biologics, and consumer health products. Comparable as a contract scientific services provider leveraging advanced infrastructure and technical expertise on behalf of smaller pharma/biotech clients; operates at much greater scale with manufacturing focus.
- Eurofins Scientific: Global leader in bioanalytical testing and contract laboratory services across food, environment, pharma, and clinical diagnostics. Comparable to Indivenire as a fee-for-service contract research provider using advanced instrumentation; vastly larger scale and broader service menu, but same fundamental business model of outsourced laboratory R&D and testing for clients lacking internal capacity.
- Evotec: Drug discovery and development CRO offering integrated outsourced R&D services to biotech and pharma clients. Comparable to Indivenire in providing outsourced scientific R&D; very different scale and focus on drug discovery vs. biosensors/biomaterials, but shares the underlying CRO business model of monetizing scientific infrastructure and expertise on behalf of resource-constrained clients.
- SGS SA: World-leading testing, inspection, and certification company offering laboratory and analytical services across life sciences and other industries. Comparable to Indivenire as a fee-for-service scientific testing and analysis provider using advanced instrumentation; vastly larger, but the surface analysis and laboratory service orientation aligns with Indivenire's XPS/ToF-SIMS/spectroscopy work.
- Lonza Group: Global contract development and manufacturing organization (CDMO) serving pharma and biotech. Comparable as an outsourced scientific services provider leveraging infrastructure and scientific expertise on behalf of smaller clients; operates at vastly larger scale with manufacturing focus vs. Indivenire's research-only R&D outsourcing model.
- Charles River Laboratories: Major contract research organization offering preclinical and laboratory services for pharmaceutical and biotech clients. Comparable to Indivenire as a CRO providing outsourced scientific services and laboratory expertise; operates at much greater scale and in regulated clinical/preclinical domains rather than SME-focused applied R&D.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Indivenire social profiles
Digital presenceIndivenire compliance and trust
Trust signalCompliance1 record
Indivenire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Indivenire leadership team
Management profileNumber of profiles
Profiles2 records
Indivenire funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Indivenire M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Indivenire
What does Indivenire do?
Indivenire provides outsourced research and development services to small and medium enterprises that cannot afford internal R&D departments. The company delivers project-based R&D contracting across biosensors, biomedical devices, molecular diagnostics, surface analysis, and biomaterials, leveraging access to specialized laboratory infrastructure at FBK (LABSSAH and MNF facilities) and a network of academic and research collaborators to help SMEs develop new products and solve technical problems without maintaining in-house staff, equipment, or laboratory space.
Is Indivenire a public or private company?
Indivenire is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Indivenire founded?
Indivenire was founded in 2018. It employs 1 to 10 people.
Where is Indivenire based?
Indivenire is headquartered in Trento, Italy, in the Europe region.
How does Indivenire make money?
One revenue line is on record: R&D Outsourcing Services.
Who are Indivenire's main competitors?
Broad incumbents on record are WuXi AppTec, Intertek Group, ICON plc, GenScript Biotech, Catalent, Eurofins Scientific, Evotec, SGS SA, Lonza Group and Charles River Laboratories.
Does Indivenire have an API?
No public API is recorded for Indivenire.
What industry is Indivenire in?
Indivenire's product category is Biotechnology Research Services. Its primary akta.pro industry code is BPAHAIAM, Instrumentation, Controls & Automation Engineering Consulting. Its NAICS code is 5417 and its SIC code is 8731.